Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,977.00
Bid: 1,979.00
Ask: 1,981.00
Change: -22.00 (-1.10%)
Spread: 2.00 (0.101%)
Open: 1,991.00
High: 2,006.00
Low: 1,977.00
Prev. Close: 1,999.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Stocks Fall After Strong Rally; Whitbread Sinks

Tue, 07th Jul 2020 08:50

(Alliance News) - Stocks in London opened lower on Tuesday as investors locked in profits, while cautiously assessing the impact of the coronavirus on the global economy.

The US is still "knee-deep" in its first wave of coronavirus infections and must act immediately to tackle the recent surge, the country's top infectious diseases expert said Monday.

Anthony Fauci said the number of cases had never reached a satisfactory baseline before the current resurgence, which officials have warned risks overwhelming hospitals in the country's south and west. The death toll from the virus in the US hit 130,000 Monday, according to a tally by Johns Hopkins University, and the number of infections is nearing three million.

The FTSE 100 index was down 45.30 points, or 0.7%, at 6,240.64. The flagship index closed up 128.64 points, or 2.1%, at 6,285.94 on Monday.

The mid-cap FTSE 250 index was down 60.96 points, or 0.4%, at 17,489.07. The AIM All-Share index was down 0.1% at 889.74.

The Cboe UK 100 index was down 0.8% at 621.44. The Cboe 250 was down 0.2% at 14,901.10, and the Cboe Small Companies was flat at 9,369.59.

In mainland Europe, the CAC 40 in Paris was down 0.9%, while the DAX 30 in Frankfurt was down 1.0%.

On the London Stock Exchange, JD Sports Fashion was the best blue-chip performer, up 3.0% after the sportswear retailer reported a record rise in annual profit.

For the 52 weeks ended February 1, the company's revenue increased 30% to GBP6.11 billion from GBP4.72 billion the year before. Pretax profit edged higher to GBP348.5 million from GBP339.9 million.

For financial 2020, JD Sports said like-for-like sales were up 12% on an annual basis, with the core UK & Ireland sales up 10%.

The results were not affected by the coronavirus pandemic lockdowns, which began in March this year, however, JD Sports said Covid-19 continues to affect its commercial operations and will have a material impact on its results for the period to January 30, 2021.

"It'll be some time before shoppers come out again in the numbers we saw before the pandemic but luckily for JD, it has a strong online presence that has performed well these past few months. Sales may be affected for a while yet, but JD is likely to come out of this economic crisis better than most," commented eToro analyst Adam Vettese.

Hikma Pharmaceuticals was up 2.5% after Morgan Stanley raised the drugmaker to Overweight from Equal Weight.

At the other end of the large-cap index, Whitbread was the worst performer, down 3.5% after the hospitality firm said first-quarter like-for-like sales slumped due to the coronavirus lockdown.

For the first quarter ended May 28, group like-for-like sales fell 80% and total sales were down 79%. Whitbread said the first-quarter performance reflects the impact of the closure of its hotel and restaurant operations, in both the UK and Germany, at the end of March.

In addition, Societe Generale downgraded the Premier Inn hotel chain owner to Sell from Hold.

In the FTSE 250, Plus500 was the best performer, up 6.5% after the online trading company said revenue in the first half nearly quadrupled and reported a record number of active customers.

Plus500 said it expects revenue of about USD564.2 million for the six months to June 30, up from USD148.0 million the year before. It gained 198,176 new customers in the first half, up from 47,540 the year before.

The Japanese Nikkei 225 index closed down 0.4%. In China, the Shanghai Composite ended up 0.9%, while the Hang Seng index in Hong Kong is down 0.3%.

The pound was quoted at USD1.2475 early Tuesday, down from USD1.2492 late Monday, with Brexit negotiations set to resume.

The EU's chief Brexit negotiator Michel Barnier will travel to London on Tuesday for talks with his UK counterpart David Frost.

Last week, discussions between the two sides on a post-Brexit trade deal broke up early with "significant differences" remaining.

But Barnier and Frost will meet face-to-face in London on Tuesday, before talks with the rest of their teams on Wednesday.

The UK's Chief Negotiator Frost said last week that though the ability to meet in person had given "extra depth and flexibility" to the discussions, there was more to do. Barnier said that while Brussels had engaged "constructively", officials needed to see an "equivalent engagement from the UK side".

The euro was quoted at USD1.1291, marginally lower from USD1.1312. Against the yen, the dollar was quoted at JPY107.47, flat from JPY107.49.

Brent oil was quoted at USD42.55 a barrel Tuesday morning, down from USD43.43 late Monday. Gold was quoted at USD1,782.28 an ounce, flat from USD1,784.81

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.